[Antihypertensive treatment with beta receptor blockers and obstructive ventilatory disorder (author's transl)].
The author reports on the results of an investigation of 100 randomly sampled hypertensives treated with beta blockers and presenting an unexpected incidence (32%) of increased airway resistance. Remarkable occurrences of bronchitis in infancy, recurrent bronchitis and chronic bronchitis are indicative of a substantially higher risk of bronchial side effects by high-dosed beta blocker therapy (e. g. antihypertensive treatment). Hints are given for the practical approach.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D001991:Bronchitis / Q000150:complications; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008173:Lung Diseases, Obstructive / Q000139:chemically induced*; D010869:Pindolol / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D011656:Pulmonary Emphysema / Q000150:complications
D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D010869:Pindolol
Antihypertensive Therapie mit Betablockern und obstruktive Ventilationsstörung.